Ablaze Pharmaceuticals

Leading the Innovative Targeted Radiotherapy Landscape in China.

General Information
Company Name
Ablaze Pharmaceuticals
Founded Year
2021
Location (Offices)
Shanghai, China +4
Founders / Decision Makers
Number of Employees
10
Industries
Biotechnology, Pharmaceutical
Funding Stage
Series A
Social Media

Ablaze Pharmaceuticals - Company Profile

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company founded in 2011 with a mission to revolutionize the targeted radiotherapy landscape in China. The company has garnered attention for its partnership with RayzeBio, Inc., a leading radiopharmaceutical firm based in San Diego, CA. This strategic alliance has granted Ablaze exclusive rights for development and commercialization of a range of RayzeBio’s products in the greater China region. With a focus on the burgeoning market for targeted radiopharmaceutical therapies (TRT), Ablaze is poised to emerge as a pioneering force in this sector in China by collaborating with key partners both domestically and internationally. The latest milestone for Ablaze Pharmaceuticals was the $75.00M Series A investment on 29 November 2021, with a consortium of prominent investors including Vivo Capital, AdvanTech Capital, Nan Fung Life Sciences, Samsara BioCapital, VenBio Partners, Pivotal bioVenture Partners China, Venrock Healthcare Capital Partners, and RAYZ Investments. Ablaze Pharmaceuticals' commitment to advancing innovative radiopharmaceutical therapies in China positions it as a compelling prospect for investment in the biotechnology and pharmaceutical industries. For more information, please visit www.ablazepharma.com.

Taxonomy: Pharmaceuticals, Clinical-stage, Radiopharmaceuticals, Cancer treatment, Targeted therapy, Drug development, Partnership, Radiopharmaceutical company, Cross-border product development, Business networking, China market, Strategic partnerships, Healthcare innovation, Oncology

Funding Rounds & Investors of Ablaze Pharmaceuticals (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A $75.00M 8 RAYZ Investments 29 Nov 2021

Latest News of Ablaze Pharmaceuticals

View All

No recent news or press coverage available for Ablaze Pharmaceuticals .

Similar Companies to Ablaze Pharmaceuticals

View All
Full-Life Technologies - Similar company to Ablaze Pharmaceuticals
Full-Life Technologies A Fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China.
NorthStar Medical Radioisotopes, LLC - Similar company to Ablaze Pharmaceuticals
NorthStar Medical Radioisotopes, LLC Our Mission: Providing Patients Global Access to Game-Changing Radiopharmaceuticals
TRT - Similar company to Ablaze Pharmaceuticals
TRT Providing cost-effective solutions for IBM, HP, Dell, Cisco EMC, Netapp & more servers, storage & networking brands
Primo Biotechnology 普瑞默生技 - Similar company to Ablaze Pharmaceuticals
Primo Biotechnology 普瑞默生技 Future in Precision|精準守護 你的未來